MedTrace Logo

China Evera MRI® Study

NCT03261063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-10-15

No results posted yet for this study

Summary

The study is a prospective, single arm, non-blinded, multi-site study conducted in mainland China.

Conditions

  • Arrhythmias, Cardiac

Interventions

DEVICE

Evera MRI ICD System

Subjects are implanted with Evera MRI ICD System and exposed to MRI environment per study requirements

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2018-09-26
Completion
2018-09-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03261063 on ClinicalTrials.gov